Abiopharma

🔍 ISQ Global Fund II GP LLC (Executive)

Company: Kinetik Holdings Inc. (KNTK)

Report Date: 2026-04-27

Detailed Transactions and Holdings:

• Sold 868 shares of Class A Common Stock at $48.0099 per share (Direct)
  Date: 2026-04-27 | Code: S | equity_swap_involved: false | shares_owned_after: 1,338,933.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 192,041 shares of Class A Common Stock at $48.5566 per share (Direct)
  Date: 2026-04-28 | Code: S | equity_swap_involved: false | shares_owned_after: 1,146,892.00 | transaction_form_type: 4 | Footnotes: F3, F2
• Sold 183,434 shares of Class A Common Stock at $49.526 per share (Direct)
  Date: 2026-04-29 | Code: S | equity_swap_involved: false | shares_owned_after: 963,458.00 | transaction_form_type: 4 | Footnotes: F4, F2

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.00 to $48.025, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F2: The securities are directly held by Buzzard Midstream LLC. ISQ Global Fund II GP, LLC ("Fund II GP") is the general partner of the members of the indirect owners of Buzzard Midstream LLC and, in such capacity, exercises voting and investment power over the securities directly held by Buzzard Midstream LLC. I Squared Capital, LLC ("I Squared Capital") is the sole member of Fund II GP. ISQ Holdings, LLC ("ISQ Holdings") is the managing member of I Squared Capital. Each of Sadek Wahba and Gautam Bhandari is a member of ISQ Holdings and disclaims beneficial ownership over the securities reported herein except to the extent of his pecuniary interest therein.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.00 to $48.92, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.955 to $49.715, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.